181 filings
Page 2 of 10
8-K
tr409
11 Apr 22
Unregistered Sales of Equity Securities
5:11pm
NT 10-K
aigjc93k
30 Dec 21
Notice of late annual filing
1:49pm
8-K
nfmusy1c4ov6d49t7tt
12 Oct 21
Regulation FD Disclosure
8:27am
8-K
q2bwqxuu4p
4 Oct 21
Regulation FD Disclosure
8:48am
8-K
7kxinmwx0d2m zt3
20 Sep 21
Multiple Sclerosis Drug Development Information September 2021
8:16am
NT 10-Q
qoc0dv4lmge37fq5brny
16 Aug 21
Notice of late quarterly filing
4:33pm
NT 10-Q
g26 pbdzn
17 May 21
Notice of late quarterly filing
11:37am
8-K
iknh1t2 6b3
6 May 21
AngioSoma, Inc. Adds Brooke Greenwald As Chief Marketing Officer
5:27pm
8-K
8vgp 5n6wk09s
5 May 21
Regulation FD Disclosure
4:17pm
8-K
61b7m559cosh6ml07j
16 Apr 21
AngioSoma, Inc. Is Pleased to Welcome William Farley to Its Board of Directors
4:20pm
8-K
15t9quqqa7nuryzrkldq
5 Mar 21
Departure of Directors or Certain Officers
8:49am
8-K
cletb7 hfyf6f09
25 Feb 21
Angiosoma and its Subsidiary Somaceuticals Announce Amended and Restated Execution of Global License for Multiple Sclerosis Patent
5:30pm
8-K
lytmfh jwk8x
22 Dec 20
Regulation FD Disclosure
5:14pm
8-K
c5oykwbi
9 Dec 20
SomaCeuticals Moving Forward With Treatment of Multiple Sclerosis
12:00am